Publications by authors named "Dirk Saleschus"

Claim this Profile
P
Prevention of non-ventilator-associated hospital-acquired pneumonia in Switzerland: a type 2 hybrid effectiveness-implementation trial.
Aline Wolfensberger, Lauren Clack, Stefanie von Felten, Mirjam Faes Hesse, Dirk Saleschus

Lancet Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel dynamics in the yield of universal SARS-CoV-2 admission screening and population incidence.
Peter W Schreiber, Thomas Scheier, Aline Wolfensberger, Dirk Saleschus, Miriam Vazquez

Sci Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland.
Aline Wolfensberger, Verena Kufner, Maryam Zaheri, Marius Zeeb, Isabelle Nortes, Dirk Saleschus

Emerg Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an electronic alert on prescription patterns of meropenem, voriconazole and caspofungin.
Lionel Chok, Katharina Kusejko, Nadia Eberhard, Sandra E Chaudron, Dirk Saleschus

BMC Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Implementation and evaluation of a care bundle for prevention of non-ventilator associated hospital-acquired pneumonia (nvHAP) - a mixed-methods study protocol for a hybrid type 2 effectiveness-implementation trial.
Aline Wolfensberger, Lauren Clack, Stefanie von Felten, Katharina Kusejko, Mirjam Faes Hesse, Dirk Saleschus

BMC Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation and evaluation of a care bundle for prevention of non-ventilator-associated hospital-acquired pneumonia (nvHAP) - a mixed-methods study protocol for a hybrid type 2 effectiveness-implementation trial.
Aline Wolfensberger, Lauren Clack, Stefanie von Felten, Katharina Kusejko, Mirjam Faes Hesse, Dirk Saleschus

BMC Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis